Oncology - OmicsDI

Show results for

Unknown (226314)
Genomics (7570)
Proteomics (1044)
Transcriptomics (492)
Clinical (167)
Models (152)
Genomic (58)
Metabolomics (45)
Other (38)
Methylation profiling (16)
Multiomics (2)

Organisms

Allexis (971)
Arabidopsis thaliana (971)
Entamoeba histolytica HM-1:IMSS-A (971)
Escherichia coli (971)
Homo sapiens (971)
Listeria monocytogenes (971)
Homo sapiens (757)
Mus musculus (108)
Canis lupus familiaris (16)
Rattus norvegicus (15)
Gallus gallus (4)
Vesicular stomatitis virus (2)
Mus sp. (2)
Hevea brasiliensis (2)
Drosophila melanogaster (2)
synthetic construct (2)
Danio rerio (2)
Cancer (1)
Mycobacterium tuberculosis variant bovis BCG (1)
Pseudomonas putida S12 (1)
Pseudoalteromonas sp. A2 (1)
Astragalus chrysochlorus (1)
Canna indica (1)
Chenopodium amaranticolor (1)
Boehmeria nivea (1)
Canis lupus (1)
Pasteurella multocida subsp. multocida str. Pm70 (1)
Pseudomonas putida (1)
Escherichia coli (1)
Mus (1)

Organisms

Homo sapiens (4431)
Mus musculus (1494)
Danio rerio (62)
Rattus norvegicus (46)
Canis lupus familiaris (28)
Saccharomyces cerevisiae (25)
Drosophila melanogaster (11)
Gallus gallus (6)
Macaca mulatta (5)
Escherichia coli (3)
Heterocephalus glaber (2)
Klebsiella pneumoniae subsp. pneumoniae (2)
Mammalia (2)
Mus (2)
Caenorhabditis elegans (2)
gut metagenome (2)
human gut metagenome (2)
unidentified (2)
synthetic construct (2)
Venezuelan equine encephalitis virus (strain TC-83) (1)
Moringa oleifera (1)
Sarocladium kiliense (1)
Mycobacterium intracellulare subsp. chimaera (1)
Synthetic plasmid (1)
Homo sapiens/Mus musculus xenograft (1)
Mediterraneibacter gnavus (1)
Paederus fuscipes (1)
Cricetulus griseus (1)
Mus musculus albula (1)
human gammaherpesvirus 4 (1)

Repository

ENA (7339)
pride (971)
geo (404)
EGA (186)
biostudies-arrayexpress (180)
BioModels (151)
dbGaP (58)
MetaboLights (43)
MassIVE (39)
iProX (29)
GPMDB (6)
PanoramaPublic (4)
EVA (2)
GNPS (2)
Cell Collective (1)

Tissue

Cell culture (230)
Epithelial cell (152)
Brain (44)
Lung (44)
Blood plasma (37)
Permanent cell line cell (34)
Blood (33)
B cell (30)
Colon (28)
Bone marrow (22)
Blood cell (21)
Liver (21)
T cell (19)
Fibroblast (18)
Kidney (18)
Blood serum (17)
Breast (17)
Pancreas (15)
HeLa cell (12)
Lymph node (12)
Melanocyte (12)
Skin (12)
Cell suspension culture (11)
Leukocyte (11)
Malignant cell (11)
Spleen (11)
Breast cancer cell (10)
Cerebrospinal fluid (10)
Heart (9)
Type II pneumocyte (9)

Disease

Breast cancer (85)
Colorectal Neoplasms (53)
Melanoma (28)
Lung cancer (27)
Cancer (16)
Neoplasms (15)
Lymphoma (14)
Non-small cell lung carcinoma (13)
Urinary bladder cancer (12)
Carcinoma (10)
Colorectal cancer (7)
Pancreatic Neoplasms (7)
Neuroblastoma (6)
Breast Cancer (5)
Lung Neoplasms (4)
Rectal Neoplasms (4)
Breast Neoplasms (3)
Neoplasm Metastasis (3)
Lymphoid leukemia (2)
Leukemia (2)
Normal (2)
Head and Neck Neoplasms (2)
Skin cancer (1)
Non-Hodgkin lymphoma (1)
Glioblastoma multiforme (1)
High risk B-precurser acute lymphoblastic leukemia (1)
Non-classic glioblastoma (1)
B-precursor acute lymphoblastic leukemia (1)
Normal tissue (1)
Bone cancer (1)

Technology Type

Mass Spectrometry (971)
Shotgun proteomics (530)
Bottom-up proteomics (159)
Affinity purification coupled with mass spectrometry proteomics (141)
Data-dependent acquisition (101)
Data-independent acquisition (42)
Gel-based experiment (40)
SWATH MS (40)
Mass spectrometry (34)
Top-down proteomics (25)
SRM/MRM (23)
Immunopeptidomics (9)
Mass spectrometry assay (8)
All-ion fragmentation (7)
Chemical cross-linking coupled with mass spectrometry proteomics (7)
Affinity proteomics (4)
DiaPASEF (4)
HDMSE (3)
NMR spectroscopy (2)
MSE (2)
Olink affinity proteomics (2)
Illumina MiSeq, Illumina HiSeq 2500, ILLUMINA (1)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina HiSeq 2500 (1)
Illumina MiSeq (1)
Glycoproteomics (1)
Mass spectrometry imaging (1)
Proteogenomics (1)

Instrument Platform

Q Exactive (25)
Instrument (6)
Illumina NovaSeq 6000 (5)
Illumina HiSeq 2000 (4)
Illumina HiSeq 4000 (4)
LTQ Orbitrap Discovery (Thermo Scientific) (3)
Orbitrap Fusion (3)
Orbitrap Fusion Lumos (3)
Ion Chef (2)
Ion Torrent S5 XL (2)
Illumina HiSeq 2500 (2)
NextSeq 500 (2)
LTQ Orbitrap (2)
LTQ Orbitrap Elite (2)
Dr. Tom Multi-omics Data Mining System (1)
Animal Experiment Facility (1)
SPF Animal Room (1)
PCR Thermocycler, Fragment Analyzer (1)
Centrifuge, Nucleic Acid Quantification Instrument (1)
Biosafety Cabinet, Liquid Nitrogen Tank, -80°C Freezer (1)
Genolab M (1)
10x Chromium Controller (1)
Axon GenePix 4000B scanner (1)
AB SOLiD 4 System (1)
Illumina NovaSeq X (1)
DNBSEQ-T7 (1)
NextSeq 550 (1)
Illumina MiSeq (1)
- (1)
ACQUITY UPLC I-Class (1)

Publication Date

2024 (346)
2025 (222)
2023 (173)
2026 (157)
2022 (154)
2021 (144)
2019 (110)
2020 (105)
2018 (68)
2017 (59)
2016 (56)
2015 (47)
2013 (31)
2012 (30)
2009 (27)
2014 (24)
2011 (17)
2010 (13)
2008 (12)
2007 (5)
2005 (5)
2006 (3)

UNIPROT ID/AC

P60568 (5)
P01137 (4)
C4NUM1 (2)
Q0GK43 (2)
P22681 (2)
P00533 (2)
P62993 (2)
Q3UNK5 (1)
P70293 (1)
S5S2F2 (1)
Q14609 (1)
A2RSY7 (1)
Q15116 (1)
P16410 (1)
Q8WXI7 (1)
Q9UK32 (1)
Q9H665 (1)
Q9ES17 (1)
O00443 (1)
Q504U8 (1)
P08887 (1)
P01579 (1)
P31751 (1)
P27361 (1)
P05231 (1)
P01133 (1)
P04049 (1)
Q02750 (1)
P62070 (1)
Q07889 (1)

CHEBI ID

CHEBI:144829 (10)
CHEBI:30769 (8)
CHEBI:32816 (6)
CHEBI:17203 (5)
CHEBI:15891 (5)
CHEBI:18050 (5)
CHEBI:16761 (5)
CHEBI:16737 (5)
CHEBI:16919 (5)
CHEBI:15354 (5)
CHEBI:17895 (5)
CHEBI:17295 (5)
CHEBI:17368 (5)
CHEBI:30813 (4)
CHEBI:16113 (4)
CHEBI:17239 (4)
CHEBI:16708 (4)
CHEBI:25017 (4)
CHEBI:28842 (4)
CHEBI:17115 (4)
CHEBI:17750 (4)
CHEBI:17012 (4)
CHEBI:15971 (4)
CHEBI:16857 (4)
CHEBI:17053 (4)
CHEBI:16015 (4)
CHEBI:17552 (4)
CHEBI:4027 (1)
CHEBI:28748 (1)
CHEBI:17234 (1)

Metabolite Name

Adenosine (6)
Allantoin (5)
Creatinine (5)
Creatine (5)
Thymine (4)
L-Lysine (4)
Capric acid (4)
Isophorone (4)
Taurine (4)
Taurocholic acid (4)
4-Hydroxybenzaldehyde (4)
Citric acid (4)
Suberic acid (4)
Malonic acid (4)
Linoleic acid (4)
L-Tryptophan (4)
Adipic acid (4)
Uric acid (4)
Xanthine (4)
Thymidine (4)
L-Tyrosine (4)
Inosine (4)
4-Nitroaniline (3)
Quinoline-4-carboxylic acid (3)
Edetic Acid (3)
N6,N6,N6-Trimethyl-L-lysine (3)
Aminocaproic acid (3)
Acetophenone (3)
Taurodeoxycholic acid (3)
Ketoleucine (3)

First Public Date

2014 (1184)
2024 (854)
2025 (752)
2023 (653)
2026 (642)
2022 (616)
2020 (521)
2021 (452)
2017 (401)
2019 (357)
2015 (290)
2018 (253)
2016 (186)
2013 (178)

Modelling Approach

Ordinary differential equation model (135)
Delayed differential equation model (2)
Random forest procedure (1)
Computational model (1)
Boolean model (1)

Study status

Completed (77)
Recruiting (31)
Not yet recruiting (15)
Terminated (14)
Active, not recruiting (11)
Not provided (10)
Withdrawn (6)
Enrolling by invitation (3)

Lab affiliation

Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (45)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (27)
European Institute of Oncology (13)
Head of Laboratory of Neuro-Oncology, Neurology, Clinical & Cancer Proteomics (11)
Dept. Oncology Pathology, Karolinska Institutet, and Scilifelab, Stockholm, Sweden (10)
Department of oncology UNIL CHUV Ludwig Institute for Cancer Research Lausanne Office B25A/04/94 Rue du Bugnon 25a, CH-1005 Lausanne (9)
European Institute of Oncology, Milan (8)
European Institute of Oncology, Milan, Italy (8)
Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden Institute of Molecular and Cell Biology, A*STAR, Singapore 138673, Singapore (6)
Clinical Proteomics Unit, Dep. of Oncology-Pathology (5)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA (5)
Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Germany (5)
Thoracic Oncology Moffitt Cancer Center Tampa, FL, USA (5)
Biological Chemistry Department David Geffen School of Medicine UCLA (4)
Center of Molecular and Cellular Oncology, Yale University (4)
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy (4)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (4)
Dept. Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Sweden (4)
Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA (4)
Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany (4)
Karolinska Institutet, Department of Oncology-Pathology (OnkPat) (4)
Lab. Neuro-Oncology and Clinical Cancer Proteomics, Erasmus Medical Center, the Netherlands (4)
Thoracic Oncology Molecular Medicine Program Moffitt Cancer Center Tampa, FL, USA (4)
AmsterdamUMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, The Netherlands (3)
Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory, Stockholm, Sweden (3)
Dept. of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Clinical proteomics mass spectrometry, Science for Life Laboratory, Sweden. (3)
Leader of the Molecular and Systems Oncology Team in the Division of Molecular Pathology at The Institute of Cancer Research, London, UK (3)
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch (3)
Medical Oncology and Pulmonology, University Hospital Tübingen, Germany (3)
Molecular Oncology Chemical Biology and Molecular Medicine Moffitt Cancer Center (3)

Keyword

Oncology (27)
Fluorouracil (10)
Oxaliplatin (10)
Leucovorin (9)
Colorectal (8)
Pembrolizumab (7)
Metastatic (6)
Irinotecan (6)
Chemotherapy (6)
Panitumumab (5)
Bevacizumab (5)
Paclitaxel (4)
Nivolumab (4)
Capecitabine (4)
MSS-CRC (3)
Carboplatin (3)
Communication (3)
Phase I (3)
Sorafenib (3)
MCRC (3)
Metastatic Colorectal Cancer (3)
Pancreatic (3)
EGFR (3)
Levoleucovorin (3)
Amgen (2)
Informed consent (2)
Patient-centered (2)
Outcomes research (2)
Palliative (2)
EGFr (2)

IsPrivate

False (151)

Submitter Keywords

Immuno-oncology (124)
Oncology (5)
Machine Learning Model (2)
FAIR-AIML (1)
TransQST (1)

Classification

bacteria (10)
viruses (3)
fungi (1)

Modification

N6 (15)
15.994915 (4)
57.021464 (4)
71.037114 (3)
N6-dimethyl-L-lysine (3)
Not available (2)
2x(15)N labeled L-lysine (1)
4 (1)
4'-dihydroxyphenylalanine (1)
4-dinitrophenyl modified residue (1)
4x(15)N labeled L-arginine (1)

Study type

Interventional (126)
Transcription profiling by array (112)
Observational (33)
RNA-seq of coding RNA (21)
Comparative genomic hybridization by array (10)
ChIP-seq (7)
Observational patient registry (6)
Transcription profiling by RT-PCR (4)
MicroRNA profiling by array (4)
Methylation profiling by array (4)
RNA-seq of coding RNA from single cells (4)
Genotyping by array (3)
Human - One-color microarray (2)
Exome sequencing (2)
RNA-seq of total RNA (2)
Other (2)
Unknown experiment type (1)
MicroRNA profiling by high-throughput sequencing (1)
Human - High-throughput sequencing (1)
Cell line - One-color microarray (1)
ATAC-seq (1)

Release Date

2022 (28945)
2021 (25927)
2025 (25505)
2023 (25200)
2024 (20935)
2020 (19534)
2019 (13883)
2018 (11758)
2017 (10288)
2016 (9330)
2015 (7972)
2014 (6513)
2013 (4143)
2012 (3398)
2026 (3392)
2011 (2651)
2010 (2145)
2009 (1646)
2008 (1093)
2007 (616)
2006 (418)
2005 (327)
2004 (201)
2003 (158)
2002 (136)
2001 (121)
2000 (94)
1999 (65)
1998 (55)
1997 (29)

Location

United States (59)
France (26)
Australia (24)
Italy (18)
Spain (14)
Canada (14)
United Kingdom (13)
Germany (12)
Belgium (8)
China (7)
Poland (6)
New Zealand (5)
India (5)
Denmark (5)
Russia (5)
Egypt (4)
Romania (4)
South Korea (4)
Hungary (4)
Netherlands (4)
Austria (4)
Taiwan (3)
Turkey (3)
Sweden (3)
Israel (3)
Czechia (3)
Japan (3)
Slovakia (2)
Hong Kong (2)
Finland (2)

Previous page
1 / 23590
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 23590
Next page

Sort by:

Relevance

Page size

The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation

Polycomb group (PcG) proteins form multiprotein complexes, called Polycomb repressive complexes (PRCs). PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through methylation of lysine (K) 27 of histone H3 (H3). Suz12 is essential for PRC2 activity and its inactivation r...

ORGANISM(S): Mus musculus

2011-08-11 | E-GEOD-31354 | biostudies-arrayexpress

Oncology

Oncology Raw sequence reads

PRJNA1049638 | ENA

Assessment of Medical Student Research Mentorship in Radiation Oncology.

Not available

S-EPMC10801644 | biostudies-literature

Assessment of Spatial Genomics for Oncology Discovery

PRJNA872761 | ENA

Transcription profiling of human newly diagnosed T-ALL patients treated in the Childrens Oncology Group (COG) T-ALL Study 9404

The clinical and cytogenetic features associated with T-cell acute lymphoblastic leukemia (T-ALL) are not predictive of early treatment failure. Based on the hypothesis that microarrays might identify patients who fail therapy, we used the Affymetrix U133 Plus 2.0 chip and prediction analysis of mic...

ORGANISM(S): Homo sapiens

2009-02-07 | E-GEOD-14618 | biostudies-arrayexpress

Electronic health records and patient registries in medical oncology departments in Spain.

Not available

S-EPMC8390424 | biostudies-literature

VA APOLLO Project - Research for Precision Oncology (RePOP)

The Research for Precision Oncology Program (RePOP) is a research activity that establishes a cohort of Veterans diagnosed with cancer and who have had genomic analyses performed on their tumor tissue as part of standard of care. All data relevant to a patient's cancer and cancer care will be...

phs001374 | dbGaP

Synthetic lethality-mediated precision oncology via the tumor transcriptome

PRJNA700986 | ENA

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

Not available

S-EPMC10163010 | biostudies-literature

Patient-derived micro-organospheres (MOS) enable clinical precision oncology

PRJNA763787 | ENA